New story in Health from Time: For the First Time in Four Years, the U.S. Life Expectancy Rose a Little

(NEW YORK) — Life expectancy in the United States is up for the first time in four years.

The increase is small — just a month — but marks at least a temporary halt to a downward trend. The rise is due to lower death rates for cancer and drug overdoses.

“Let’s just hope it continues,” said Robert Anderson, who oversees the report released Thursday by the Centers for Disease Control and Prevention.

The latest calculation is for 2018 and factors in current death trends and other issues. On average, an infant born that year is expected to live about 78 years and 8 months, the CDC said.

For males, it’s about 76 years and 2 months; for females 81 years and 1 month.

For decades, U.S. life expectancy was on the upswing, rising a few months nearly every year. But from 2014 to 2017, it fell slightly or held steady. That was blamed largely on surges in overdose deaths and suicides.

Suicides continued to increase in 2018, as did deaths from the flu and pneumonia during what turned out to be an unusually bad flu year. But declines in some other causes of death — most notably cancer and drug overdoses — were enough to overcome all that, according to the report.

Cancer is the nation’s No. 2 killer, blamed for about 600,000 deaths a year, so even slight changes in the cancer death rate can have a big impact. The rate fell more than 2%, matching the drop in 2017.

“I’m a little surprised that rapid pace is continuing,” said Rebecca Siegel, a researcher for the American Cancer Society.

Most of the improvement is in lung cancer because of fewer smokers and better treatments, she said.

Also striking was the drop in drug overdose deaths that had skyrocketed through 2017. The death rate fell 4% in 2018 and the number of deaths dropped to about 67,400.

Deaths from heroin and prescription painkillers went down, however, deaths from other drugs — fentanyl, cocaine and meth — continued to go up. And preliminary data for the first half of 2019 suggest the overall decline in overdose deaths is already slowing down.

It’s still a crisis, said Katherine Keyes, a Columbia University researcher. “But the fact that we have seen the first year where there’s not an additional increase is encouraging.”

The national decline was driven by dips in 14 states, the CDC’s Anderson said. Those include states where overdose deaths have been most common, like Ohio, Pennsylvania, Kentucky, and West Virginia.

In Ohio’s Hamilton County, which includes Cincinnati, overdose deaths fell in 2018 and preliminary data indicates another drop last year. County health commissioner Tim Ingram credited efforts to try to expand access to treatment, and to widely distribute the overdose reversal drug Narcan.

“We almost saturated our community with Narcan,” he said.

Nationally, for all causes of death, more than 2.8 million Americans died in 2018. That’s about 26,000 more than the year before, the CDC report found. The number went up even as the death rate went down, because the population is growing and a large group are retirement age baby boomers.

Other findings:

— The 10 leading causes of death remained the same, with heart disease at No. 1. The death rate for heart disease declined slightly, by less than 1%.

— Death rates also dropped for stroke, Alzheimer’s disease, chronic lower respiratory diseases and unintentional injuries, which includes drug overdoses.

— Americans who were 65 in 2018 are expected to live another 19 years and six months, on average.

— The infant mortality rate fell more than 2%, to 1 in 177 births.

— The suicide death rate hit its highest level since 1941 — about 14 per 100,000. The rate peaked during the Depression in 1932 then mostly declined until 2000. It’s been rising most years since then.

The U.S. has the highest suicide rate of 11 wealthy nations studied, according to a separate report released Thursday by the private Commonwealth Fund. That report also found U.S. life expectancy is two years lower that the average for the 10 other wealthy nations.

New story in Health from Time: COVID-19 Has Been ‘Apocalyptic’ for Public Transit. Will Congress Offer More Help?

While trying to get to work over the past few months, Brittany Williams, a Seattle home care worker, has often been passed by two or three buses before one stops to let her board. Buses in her area that once carried anywhere from about 50 to 100 passengers have been limited to between 12 and 18 to prevent overcrowding in response to coronavirus, and Williams’ commute, typically a half-hour ride, now takes more than double that time. Other Seattle transit riders have described budgeting as much as an extra hour per trip to account for the reduced capacity, eating into their time at work, school or with family. Even with the ridership limits in place, Williams, 34, doesn’t feel safe on public transit. Some passengers don’t wear face coverings, and bus drivers sometimes ignore capacity limits, she says. On one ride with her seven-year-old son, she decided to get off at a stop far from her home after a driver allowed a crowd of people to board. “It’s very trying. I’ll put...

New story in Health from Time: An At-Home Coronavirus Test May Be On the Way in the U.S.

As cases of COVID-19 continue to climb in the U.S. , there’s a new urgency to make sure there are as many tests as possible to diagnose people who have symptoms that might indicate an infection. Knowing if people are positive is important for guiding their next steps: self-isolation, avoiding contact with others, and, if their symptoms get worse, seeking medical care. To date, access to tests has been spotty at best across the country, and while more kits are now available than even a week ago , most are gene-based assays that take several days for commercial labs to process and produce results. That may change in about two months if the Food and Drug Administration (FDA) gives Emergency Use Authorization to the first blood-based COVID-19 test in the U.S. Scanwell Health, an at-home test company based in California, licensed the rights to a test developed by Chinese company Innovita, which was used extensively at the height of country’s epidemic earlier this year. “The ...

New story in Health from Time: A Montana Care Home Refused Free COVID-19 Tests. Now, Nearly Every Resident Has Coronavirus

(BILLINGS, Mont.) — It was meant to be a last line of defense to protect the most vulnerable as the coronavirus spread across the United States : Montana officials offered free testing in May for staff and residents at assisted living and long-term care facilities. But not all of them followed through, according to state data, including a facility in Billings, Montana’s largest city, that cares for people with dementia and other memory problems. The virus has infected almost every resident and killed eight, accounting for almost a quarter of Montana’s 34 confirmed deaths. Thirty-six employees also have tested positive at the facility where 59 people lived before the deaths began. Read more: ‘It’s Getting Worse.’ Nursing Home Workers Confront Risks in Facilities Devastated by Coronavirus While Montana’s rates of confirmed infections and deaths are much lower than other parts of the country, the outbreak at Canyon Creek Memory Care illustrates that even the most simple an...

Apple Tv Airplay Not Working

Search This Blog